+1 877 705 191424 / 7
HIPAA Compliant
ISO 27001 Certified

Completed

Phase 3
Age: 18Years - 75Years
All Genders
ID00000478

Asymptomatic Cardiac Ischemia Pilot (ACIP) Study

Led by National Heart, Lung, and Blood Institute (NHLBI) · Updated on 2016-03-25

N/A

Participants Needed

N/A

Research Sites

N/A

Total Duration

On this page

AI-Summary

What this Trial Is About

To assess the feasibility of and test the methodology for a full-scale clinical trial of therapies for asymptomatic cardiac ischemia.

CONDITIONS

Brief Title

Asymptomatic Cardiac Ischemia Pilot (ACIP) Study

Who Can Participate

Age: 18Years - 75Years
All Genders

Eligibility Criteria

Men aand women with angiographically documented coronary artery disease, ischemia on both stress (exercise) testing and 48-hour ambulatory electrocardiogram monitoring, and who were amenable to revascularization.

Trial Site Locations

Site Locations not provided

Location information for this trial is currently unavailable.

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here